Walleye Capital LLC Logic Bio Therapeutics, Inc. Transaction History

Walleye Capital LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$0.61 - $2.49 $6,663 - $27,200	-10,924 Closed	0 $0
Q4 2021 Mar 03, 2022	BUY	$2.2 - $4.53 $24,032 - $49,485	10,924 New	10,924 $25,000
Q3 2021 Nov 15, 2021	SELL	$3.85 - $5.09 $91,926 - $121,533	-23,877 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$4.03 - $7.57 $96,224 - $180,748	23,877 New	23,877 $106,000

Ticker LOGC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 32,962,700
Description
LogicBio Therapeutics, Inc., a genetic medicine company, focuses on developing and commercializing genome editing and gene therapy treatments using its GeneRide and sAAVy platforms. The company's GeneRide technology is a new approach to precise gene insertion harnessing a cell's natural deoxyribonucleic acid; and gene delivery platform, sAAVy is...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.